A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.
Optimizing TV Targeting in a Fragmented Landscape Advances Better Patient Outcomes
Connecting with the right audiences with precision and impact across all channels allows pharmaceutical companies to enhance patient engagement and drive better health outcomes. In addition to helping patients by connecting them with new information, consumer ads positively influence healthcare providers (HCP) prescribing behavior.
Swoop spoke with Suda Shinya, Senior Vice President of Information Systems for Astellas Pharma on how to proactively meet the needs of a digital-first patient.
Swoop’s [email protected] discusses how medical marketers can leverage ML and AI to reach privacy safe DTC audiences and highly valuable HCP influencers.
Swoop utilizes ML, AI & RWD to uncover precise, privacy-safe segments of ideal patients that are higher in audience quality & drive increased script lift